Literature DB >> 10966289

Pathophysiology of septic encephalopathy: a review.

M C Papadopoulos1, D C Davies, R F Moss, D Tighe, E D Bennett.   

Abstract

OBJECTIVES: Encephalopathy is a common complication of sepsis. This review describes the different pathologic mechanisms that may be involved in its etiology. DATA SOURCES: The studies described here were derived from the database PubMed (http:¿¿www.nlm.nih.gov) and from references identified in the bibliographies of pertinent articles and books. The citations are largely confined to English language articles between 1966 and 1998. Older publications were used if they were of historical significance. STUDY SELECTION: All investigations in which any aspect of septic encephalopathy was reported were included. This selection encompasses clinical, animal, and in vitro cell culture work. DATA EXTRACTION: The literature cited was published in peer-reviewed clinical or basic science journals or in books. DATA SYNTHESIS: Contradictions between the results of published studies are discussed.
CONCLUSIONS: The most immediate and serious complication of septic encephalopathy is impaired consciousness, for which the patient may require ventilation. The etiology of septic encephalopathy involves reduced cerebral blood flow and oxygen extraction by the brain, cerebral edema, and disruption of the blood-brain barrier that may arise from the action of inflammatory mediators on the cerebrovascular endothelium, abnormal neurotransmitter composition of the reticular activating system, impaired astrocyte function, and neuronal degeneration. Currently, there is no treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10966289     DOI: 10.1097/00003246-200008000-00057

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  66 in total

1.  Studying septic encephalopathy: what animal models can predict.

Authors:  Stefan Schraag
Journal:  Intensive Care Med       Date:  2003-05       Impact factor: 17.440

2.  Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus-associated encephalopathy-like changes in neonatal mice.

Authors:  Tomohisa Tanaka; Yuji Sunden; Yoshihiro Sakoda; Hiroshi Kida; Kenji Ochiai; Takashi Umemura
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

Review 3.  Neuro-oxidative-nitrosative stress in sepsis.

Authors:  Ronan M G Berg; Kirsten Møller; Damian M Bailey
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-13       Impact factor: 6.200

Review 4.  Cerebral hemodynamics in sepsis assessed by transcranial Doppler: a systematic review and meta-analysis.

Authors:  Daniel Silva de Azevedo; Angela Salomao Macedo Salinet; Marcelo de Lima Oliveira; Manoel Jacobsen Teixeira; Edson Bor-Seng-Shu; Ricardo de Carvalho Nogueira
Journal:  J Clin Monit Comput       Date:  2016-10-18       Impact factor: 2.502

Review 5.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 6.  Cerebral perfusion in sepsis.

Authors:  Christoph S Burkhart; Martin Siegemund; Luzius A Steiner
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

7.  Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans.

Authors:  Ronan Mg Berg; Sarah Taudorf; Damian M Bailey; Carsten Lundby; Fin Stolze Larsen; Bente Klarlund Pedersen; Kirsten Møller
Journal:  Crit Care       Date:  2010-02-11       Impact factor: 9.097

8.  Cerebral microcirculation is impaired during sepsis: an experimental study.

Authors:  Fabio Silvio Taccone; Fuhong Su; Charalampos Pierrakos; Xinrong He; Syril James; Olivier Dewitte; Jean-Louis Vincent; Daniel De Backer
Journal:  Crit Care       Date:  2010-07-28       Impact factor: 9.097

9.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

10.  Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.

Authors:  Eléonore Beurel; Richard S Jope
Journal:  J Neuroinflammation       Date:  2009-03-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.